In a meta-analysis that included 50 studies (involving 33,514 subjects), Yin et al. [43] showed that the IL6 promoter polymorphisms (−572G > C and −174G > C) influence IL6 gene transcription and are associated with an increased level of circulating inflammatory markers and an increased risk for atherosclerosis [43]. Here, IL6 is linked to atherosclerosis.